Abstract
Aspartame, a high intensity sweetener, is used extensively worldwide in over 5,000 products. Upon ingestion, aspartame is completely metabolized to two amino acids and methanol (approximately 50% phenylalanine, 40% aspartic acid, and 10% methanol). The effects of aspartame on cognitive function, electroencephalograms (EEGs) and biochemical parameters were evaluated in 48 adult (21 men, 27 women) heterozygotes for phenylketonuria (PKUH). PKUH subjects whose carrier status had been proven by DNA analysis ingested aspartame (either 15 or 45 mg/kg/day) and placebo for 12 weeks on each treatment using a randomized, doubleblind, placebo-controlled, crossover study. A computerized battery of neuropsychological tests was administered at baseline weeks -2 and -1, and during treatment at weeks 6, 12, 18, and 24. Samples for plasma amino acids and urinary organic acids were also collected during these visits. EEGs were evaluated by conventional and spectral analysis at baseline week -1 and treatment weeks 12 and 24. The results of the neuropsychological tests demonstrated that aspartame had no effect on cognitive function. Plasma phenylalanine significantly increased, within the normal range for PKUH, at 1 and 3 h following the morning dose of aspartame in the group receiving the 45 mg/kg per day dose only. There were no significant differences in the conventional or spectral EEG analyses, urinary organic acid concentrations, and adverse experiences when aspartame was compared with placebo. This study reaffirms the safety of aspartame in PKUH and refutes the speculation that aspartame affects cognitive performance, EEGs, and urinary organic acids.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bartholomé K, Lutz P, Bickel H (1975) Determination of phenylalanine hydroxylase activity in patients with phenylketonuria and hyperphenylalaninemia. Pediatr Res 9:899–903
Benninger C, Matthis P, Scheffner D (1984) EEG development of healthy boys and girls. Results of a longitudinal study. Electroencephal Clin Neurophysiol 57:1–12
Benninger C, Matthis P, Scheffner D (1985) Spectral analysis of the EEG in children during the introduction of antiepileptic therapy with valproic acid. Neuropsychobiology 13:93–96
Burns TS, Stargel WW, Tschanz C, Kotsonis FN, Hurwitz A (1991) Aspartame and sucrose produce a similar increase in the plasma phenylalanine to large neutral amino acid ratio in healthy subjects. Pharmacology 43:210–219
Butchko HH, Kotsonis FN (1989) Aspartame: review of recent research. Comments Toxicol 3:253–278
Butchko HH, Kotsonis FN (1991) Acceptable daily intake vs actual intake: the aspartame example. J Am Coll Nutr 10:258–266
De Sonneville LMJ (1993) SVAT: a computer-based approach to development and disorders of information processing. In: Maarse FJ, Akkerman AE, Brand N, Mulder LJM, van der Stelt M (eds) Computers in psychology: tools for experimental and applied psychology, vol 4. Swets & Zeitlinger, Lisse, pp 168–176
De Sonneville LMJ, Njiokiktjien C (1988) Pediatric behavioural neurology, vol II. Aspects of information processing. Suyi, Amsterdam
De Sonneville LMJ, Schmidt E, Michel U, Batzler U (1990) Preliminary neuropsychological test results. Eur J Pediatr 149 [Suppl 1]:S39-S44
Elsas LJ II, Trotter JF (1988) Changes in physiological concentrations of blood phenylalanine produce changes in sensitive parameters of human brain function. In: Wurtman RJ, Ritter-Walker E (Eds) Dietary phenylalanine and brain function, chapter 22. Birkhauser, Boston, Mass, pp 187–195
Epstein CM, Trotter JF, Averbook A, Freeman S, Kutner MH, Elsas LJ (1989) EEG mean frequencies are sensitive indices of phenylalanine effects on normal brain. Electroencephalogr Clin Neurophysiol 72:133–139
Fernstrom JD (1990) Aromatic amino acids and monamine synthesis in the central nervous system: influence of the diet. J Nutr Biochem 1:508–517
Fleiss JL (1981) Statistical methods for rates and proportions. Wiley, New York, pp 113–119
Ford RC, Berman JL (1977) Phenylalanine metabolism and intellectual functioning among carriers of phenylketonuria and hyperphenylalaninemia. Lancet I:767–771
Grimm U, Knapp A, Schlenzka K, Hesse R (1977) Phenylalaninhydroxylase-Aktivität bei heterozygoten Anlageträgern für das Phenylketonurie-Gen. Acta Biol Med Germ 36:1179–1182
Hoffmann G, Aramaki S, Blum-Hoffmann E, Nyhan WL, Sweetman L (1989) Quantitative analysis for organic acids in biological samples: batch isolation followed by gas chromatographic-mass spectrometric analysis. Clin Chem 35:587–595
Janssen PJCM, Van der Heijden CA (1988) Aspartame: review of recent experimental and observational data. Toxicology 50: 1–26
Lichter-Konecki U, Schlotter M, Konecki DS, Labeit S, Woo SLC, Trefz FK (1988) Linkage disequilibrium between mutation and RFLP haplotype at the phenylalanine hydroxylase locus in the German population. Hum Genet 78:347–352
Lidsky AS, Ledley FD, DiLella AG, Kwok SCM, Daiger SP, Robson KJH, Woo SLC (1985) Extensive restriction site polymorphism at the human phenylalanine hydroxylase locus and application in prenatal diagnosis of phenylketonuria. Am J Hum Genet 37:619–634
Maher TJ, Wurtman RJ (1987) Possible neurological effects of aspartame, a widely used food additive. Environ Health Perspect 75:53–57
Matalon R, Michals K, Sullivan D, Wideroff L, Levy P (1988) Aspartame consumption in normal individuals and carriers for phenylketonuria. In: Wurtman RJ, Ritter-Walker E (eds) Dietary phenylalanine and brain function, chapter 4. Birkhauser, Boston, Mass, pp 41–52
Okano Y, Eisensmith R, Guttler F, Lichter-Konecki U, Konecki D, Trefz F, Dasovich M, Wang T, Henriksen K, Lou H, Woo S (1991) Molecular basis of phenotypic heterogeneity in phenylketonuria. N Engl J Med 324:1232–1238
Pietz J, Schmidt E, Matthis P, Kobialko B, Kutscho A, de Sonneville L (1993) EEGs in phenylketonuria. I. Follow-up to adulthood; II. Short-term diet-related changes in EEGs and cognitive function. Dev Med Child Neurol 35:54–64
Qureshi GA, Fohlin L, Bergström J (1984) Application of high-performance liquid chromatography to the determination of free amino acids in physiological fluids. J Chromatogr 297:91–100
Schmidt E, Rupp A, Burgard P, Pietz J (1992) Information processing in early-treated phenylketonuria (PKU) (abstract). J Clin Exp Neuropsychol 14:388
Scriver CR, Kaufman S, Woo SLC (1989) The hyperphenylalaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw Hill, New York, pp 495–546
Sternberg S (1969) The discovery of processing stages: extensions of Donders' method. Acta Psychologica 30:276–315
Tanaka K, West-Dull A, Hine DG, Lynn TB, Lowe T (1980) Gas-chromatographic method of analysis for urinary organic acids. II. description of the procedure, and its application to diagnosis of patients with organic acidurias. Clin Chem 26:1847–1853
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Trefz, F., de Sonneville, L., Matthis, P. et al. Neuropsychological and biochemical investigations in heterozygotes for phenylketonuria during ingestion of high dose aspartame (a sweetener containing phenylalanine). Hum Genet 93, 369–374 (1994). https://doi.org/10.1007/BF00201660
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00201660